Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: News

I agree with alomost everything you ahve said, we do need some more "press space" if we wnat interested investors to move inot the stock and hopefully give it some momentum for an upward push.

My only disagreement is that your "Super Bowl: analogy is a littte premature. IMO it's more like we made the playoffs and we have afew more "contests" to win before we can sell our Super Bowl merchandise and even tickets to he big game.

Thats' our problem right now, the future has a ton of "POTENTIAL" but it's real hard to MARKET potential until we can prove for certain that we evn have a Super Bowl to attend.

It's that potential that many of us have taken a roll of dice on to get some great returns. Right now though, we and th PR guys are having a tough sell on what could be as compared to what is for fact certain.

The sooner the PTO and Trial are behind us the better, and until that "verdict' has come to pass we could very easily linger around this level for a few more months.

A few more deals like that announced today surely should help in the meantime. JMHO..GLTA

 

Share
New Message
Please login to post a reply